Recent Developments in EU Merger Remedies

摘要

1. After an eight-year high intervention rate in 2016, the Commission's intervention rate reverted to average levels in 2017. 2. The Commission maintained preference for clear-cut divestitures despite global trend towards increased reliance on behavioural remedies. 3. Innovation concerns remained at the forefront of the Commission's merger remedy policy and have materialised most notably in Dow/DuPont. 4. The Commission displayed a flexible approach to well-crafted carve-outs.